SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001633
Filing Date
2023-08-09
Accepted
2023-08-09 16:36:14
Documents
76
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nwbo-20230630x10q.htm   iXBRL 10-Q 2142540
2 EX-21.1 nwbo-20230630xex21d1.htm EX-21.1 6862
3 EX-21.2 nwbo-20230630xex21d2.htm EX-21.2 8006
4 EX-31.1 nwbo-20230630xex31d1.htm EX-31.1 13021
5 EX-32.1 nwbo-20230630xex32d1.htm EX-32.1 8892
6 GRAPHIC nwbo-20230630xex21d2001.jpg GRAPHIC 3918
7 GRAPHIC nwbo-20230630xex21d2002.jpg GRAPHIC 10196
8 GRAPHIC nwbo-20230630xex21d2003.jpg GRAPHIC 34900
  Complete submission text file 0001410578-23-001633.txt   10153320

Data Files

Seq Description Document Type Size
9 EX-101.SCH nwbo-20230630.xsd EX-101.SCH 78202
10 EX-101.CAL nwbo-20230630_cal.xml EX-101.CAL 55348
11 EX-101.DEF nwbo-20230630_def.xml EX-101.DEF 348074
12 EX-101.LAB nwbo-20230630_lab.xml EX-101.LAB 530932
13 EX-101.PRE nwbo-20230630_pre.xml EX-101.PRE 473165
70 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20230630x10q_htm.xml XML 1983190
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 231155778
SIC: 2834 Pharmaceutical Preparations